162 related articles for article (PubMed ID: 34026068)
21. LncRNA GAS5 Suppresses the Proliferation and Invasion of Osteosarcoma Cells via the miR-23a-3p/PTEN/PI3K/AKT Pathway.
Liu J; Chen M; Ma L; Dang X; Du G
Cell Transplant; 2020; 29():963689720953093. PubMed ID: 33121268
[TBL] [Abstract][Full Text] [Related]
22. Long Noncoding RNA MAGI2-AS3 Represses Cell Progression in Clear Cell Renal Cell Carcinoma by Modulating the miR-629-5p/PRDM16 Axis.
Yan C; Wang P; Zhao C; Yin G; Meng X; Li L; Cai S; Meng B
Crit Rev Eukaryot Gene Expr; 2023; 33(7):43-56. PubMed ID: 37602452
[TBL] [Abstract][Full Text] [Related]
23. MAGI2-AS3 rs7783388 polymorphism contributes to colorectal cancer risk through altering the binding affinity of the transcription factor GR to the MAGI2-AS3 promoter.
Yang X; Wu S; Li X; Yin Y; Chen R
J Clin Lab Anal; 2020 Oct; 34(10):e23431. PubMed ID: 32533587
[TBL] [Abstract][Full Text] [Related]
24. LncRNA MAGI2-AS3 Overexpression Sensitizes Esophageal Cancer Cells to Irradiation Through Down-Regulation of HOXB7
Cheng W; Shi X; Lin M; Yao Q; Ma J; Li J
Front Cell Dev Biol; 2020; 8():552822. PubMed ID: 33330444
[TBL] [Abstract][Full Text] [Related]
25. Long noncoding RNA MAGI2-AS3/miR-218-5p/GDPD5/SEC61A1 axis drives cellular proliferation and migration and confers cisplatin resistance in nasopharyngeal carcinoma.
Cao C; Zhou S; Hu J
Int Forum Allergy Rhinol; 2020 Aug; 10(8):1012-1023. PubMed ID: 32450008
[TBL] [Abstract][Full Text] [Related]
26. Hypermethylation-Mediated lncRNA MAGI2-AS3 Downregulation Facilitates Malignant Progression of Laryngeal Squamous Cell Carcinoma via Interacting With SPT6.
Wang J; Yang C; Cao H; Yang J; Meng W; Yu M; Yu L; Wang B
Cell Transplant; 2023; 32():9636897231154574. PubMed ID: 36852700
[TBL] [Abstract][Full Text] [Related]
27. lncRNA MAGI2-AS3 suppresses castration-resistant prostate cancer proliferation and migration via the miR-106a-5p/RAB31 axis.
Yang G; Li T; Liu J; Quan Z; Liu M; Guo Y; Wu Y; Ou L; Wu X; Zheng Y
Genomics; 2023 Mar; 115(2):110599. PubMed ID: 36889366
[TBL] [Abstract][Full Text] [Related]
28. LncRNA MAGI2-AS3 inhibits bladder cancer progression by targeting the miR-31-5p/TNS1 axis.
Tang C; Cai Y; Jiang H; Lv Z; Yang C; Xu H; Li Z; Li Y
Aging (Albany NY); 2020 Nov; 12(24):25547-25563. PubMed ID: 33231563
[TBL] [Abstract][Full Text] [Related]
29. LncRNA MAGI2-AS3 is downregulated in non-small cell lung cancer and may be a sponge of miR-25.
Sui Y; Chi W; Feng L; Jiang J
BMC Pulm Med; 2020 Mar; 20(1):59. PubMed ID: 32138716
[TBL] [Abstract][Full Text] [Related]
30. LncRNA MAGI2-AS3-Encoded Polypeptide Restrains the Proliferation and Migration of Breast Cancer Cells.
Zhang Z; Yi Y; Wang Z; Zhang H; Zhao Y; He R; Luo Y; Cui Z
Mol Biotechnol; 2024 Jun; 66(6):1409-1423. PubMed ID: 37358745
[TBL] [Abstract][Full Text] [Related]
31. lncRNA MAGI2-AS3 Prevents the Development of HCC via Recruiting KDM1A and Promoting H3K4me2 Demethylation of the RACGAP1 Promoter.
Pu J; Wang J; Wei H; Lu T; Wu X; Wu Y; Shao Z; Luo C; Lu Y
Mol Ther Nucleic Acids; 2019 Dec; 18():351-362. PubMed ID: 31629962
[TBL] [Abstract][Full Text] [Related]
32. Role of MAGI2-AS3 in malignant and non-malignant disorders.
Taheri M; Askari A; Hussen BM; Ghafouri-Fard S; Rashnoo F
Pathol Res Pract; 2023 Jun; 246():154530. PubMed ID: 37196468
[TBL] [Abstract][Full Text] [Related]
33. Long non-coding RNA MAGI2
Wei X; Hou Y; Zhang Y; Zhang H; Sun Z; Meng X; Wang Z
J Cancer; 2022; 13(1):343-353. PubMed ID: 34976194
[TBL] [Abstract][Full Text] [Related]
34. Silencing of lncRNA MEG8 Represses the Viability, Migration, and Invasion of Wilms' Tumor Cells through Mediating miR-23a-3p/CRK Axis.
Shen J; Shu Q
Urol Int; 2022; 106(10):1075-1087. PubMed ID: 34518485
[TBL] [Abstract][Full Text] [Related]
35. Long noncoding RNA MAGI2-AS3 regulates CCDC19 expression by sponging miR-15b-5p and suppresses bladder cancer progression.
Wang F; Zu Y; Zhu S; Yang Y; Huang W; Xie H; Li G
Biochem Biophys Res Commun; 2018 Dec; 507(1-4):231-235. PubMed ID: 30442369
[TBL] [Abstract][Full Text] [Related]
36. Identification and Verification of a Novel MAGI2-AS3/miRNA-374-5p/FOXO1 Network Associated with HBV-Related HCC.
Wang C; Su K; Lin H; Cen B; Zheng S; Xu X
Cells; 2022 Nov; 11(21):. PubMed ID: 36359865
[TBL] [Abstract][Full Text] [Related]
37. LncRNA MAGI2-AS3 is involved in cervical squamous cell carcinoma development through CDK6 up-regulation.
Liu Q; Liu S; Wang X; Zhang J; Liu K
Infect Agent Cancer; 2019; 14():37. PubMed ID: 31832086
[TBL] [Abstract][Full Text] [Related]
38. Targeting MAGI2-AS3-modulated Akt-dependent ATP-binding cassette transporters as a possible strategy to reverse temozolomide resistance in temozolomide-resistant glioblastoma cells.
Chen Z; Zhou J; Liu Y; Ni H; Zhou B
Drug Dev Res; 2023 Nov; 84(7):1482-1495. PubMed ID: 37551766
[TBL] [Abstract][Full Text] [Related]
39. LncRNA HOXA-AS3 Promotes the Progression of Pulmonary Arterial Hypertension through Mediation of miR-675-3p/PDE5A Axis.
Li ZK; Gao LF; Zhu XA; Xiang DK
Biochem Genet; 2021 Oct; 59(5):1158-1172. PubMed ID: 33687636
[TBL] [Abstract][Full Text] [Related]
40. Long non-coding RNA (lncRNA) MAGI2-AS3 inhibits breast cancer cell growth by targeting the Fas/FasL signalling pathway.
Yang Y; Yang H; Xu M; Zhang H; Sun M; Mu P; Dong T; Du S; Liu K
Hum Cell; 2018 Jul; 31(3):232-241. PubMed ID: 29679339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
